Latest Current Report
Filed: 2026-01-08
Key Insights
- Xencor's cash, cash equivalents, and marketable debt securities as of December 31, 2025 were approximately $611 million, down from $706.7 million a year earlier, indicating a potential increase in R&D spending or other operational costs.
- Despite the decrease in cash position, Xencor expects to have sufficient funds to support its research and development programs and operations through 2028, providing financial stability and runway for continued growth.
- The preliminary cash estimates are unaudited and may differ from the final reported figures, so investors should wait for the full financial statements to get a complete picture of Xencor's financial position and performance.